Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months.

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Members and external experts

Roberto D’Amico

Roberto D’Amico

Roberto D’Amico is Assistant Professor of Biostatistics at the Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia.

In 2012, he became Director of the Italian Cochrane Centre.

He gained a degree in statistics from the University “La Sapienza” of Rome and obtained his PhD in Public Health at University of Modena and Reggio Emilia, Italy.

His main research interest is in the methodology of clinical trials, systematic reviews, meta-analysis of randomised and non-randomised studies. Besides these interests, he is also involved in projects aimed at improving the way the results of systematic reviews are transferred to health professionals, the public, guideline developers and policy makers.

He is an active Cochrane reviewer.

Roberto D’Amico is also methodological editor of the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group, editor of the Testing Treatments Interactive Editorial Alliance and co-convenor of the Cochrane Agenda and Priority Setting Methods Group.

His publication record includes over 120 journal articles.

Declaration of interests